Working with us

We work with innovators at the forefront of drug discovery to help transform bold ideas into life-changing therapies and technologies






























Make every move count

We work with innovators at the forefront of drug discovery to help transform bold ideas into life-changing therapies and technologies.

Whether you are biotech entrepreneur,  academic scientist, or drug discovery innovator, our support is designed to reduce risk, build momentum, and accelerate your path to commercialisation.

We combine our team’s deep scientific expertise with state-of-the-art technology and a detailed understanding of patient and market needs to co-design and execute effective drug strategies.

From lab-based experimentation to industrial consultancy, we apply patient and market insights to determine the quickest, safest, and most effective way to develop new medicines.​

We ask the right questions at the right time and validate your ideas through our expertise, data, insights, and technology to create a roadmap for commercial success.


























How you can work with us

We recognise that innovation journeys are complex, and every project is different. That is why we tailor our collaboration model to suit your goals, helping you advance with confidence, speed, and clarity. You can work with us through:

Lab-based discovery support

We can undertake cutting-edge laboratory work to generate decision-critical data and validate your concepts using the latest tools in in vitro biology, in vivo biology and biomarkers.

Strategic planning and expert consultancy

From target selection to first-in-human readiness, we offer tailored guidance to help you navigate the drug discovery process. We can develop robust strategies that safeguard your IP and maximise your commercial potential.

Flexible partnership models

We have various models to work in partnership with you, flexible to your needs:

  • Shared risk and reward
    We co-develop solutions through strategic collaborations, sharing both risk and outcome. These projects tackle industry-wide challenges or test emerging technologies in diverse, real-world contexts.
  • Collaborative R&D services
    We connect innovators across academia, industry, the NHS, and government, helping form powerful consortia. With experience in securing non-dilutive funding, we turn collaborative R&D into clinical and commercial breakthroughs.
  • Fee-for-service projects
    Do you need access to expert capabilities or facilities not available elsewhere? We provide managed access to our technology and team on a commercial basis, ensuring your project benefits from our unique infrastructure.
  • Signposting and connectivity
    We have deep knowledge of the drug discovery landscape across public and private sectors. We can connect you to the right partner or supplier to help make your next move count.



Partner with us and deliver impact

As a not-for-profit national Life Sciences service, we reinvest our commercial revenue back into the drug discovery ecosystem. That means your progress fuels broader innovation.

Since our inception, we have:

  • Supported over 323 organisations.
  • Helped secure over £1.53bn in R&D investment for SMEs.
  • Through our partnerships, we have developed National Programmes that address global challenges for patient unmet need.

Our team of 140+ scientists, strategists and technologists operate from Alderley Park and are united by one goal, to reshape drug discovery for patient benefit.


Three people engaged in conversation indoors.






“We are focused on transforming great science into better treatments for patients. We share your ambition. Your success is our success.”

Professor Chris Molloy, Chief Executive Officer

Chris Molloy, CEO of Medicines Discovery Catapult.






Make your next move count

From de-risking early-stage concepts to advancing preclinical assets, we are ready to help shape your next breakthrough.

Speak to us today and see how we can help make your next count.